Lv31
300 积分 2024-06-12 加入
Immune checkpoint inhibitor-induced pure red cell aplasia: Case series and large‐scale pharmacovigilance analysis
9小时前
已完结
Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients
6天前
已完结
An Optimized LC-MS/MS Method for Quantification of Sunitinib and N-Desethyl Sunitinib in Human Plasma and Its Application for Therapeutic Drug Monitoring
11天前
已完结
Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non–Small-Cell Lung Cancer
2个月前
已完结
Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer
2个月前
已完结
Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting
2个月前
已完结
The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib
2个月前
已完结
Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric Patients
2个月前
已完结
Drug Reaction With Eosinophilia and Systemic Symptoms in Children
2个月前
已完结
Antimicrobial Exposure and Immune-Related Cutaneous Adverse Events During Immune Checkpoint Blockade Therapy
2个月前
已关闭
皖公网安备34019202002308
